Concepts (256)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Costello Syndrome | 8 | 2022 | 16 | 2.060 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 3 | 2019 | 45 | 1.410 |
Why?
|
| Behavior Therapy | 4 | 2022 | 271 | 1.250 |
Why?
|
| Child Behavior Disorders | 3 | 2016 | 71 | 1.130 |
Why?
|
| Disorders of Sex Development | 6 | 2019 | 70 | 1.060 |
Why?
|
| Gender Identity | 4 | 2023 | 74 | 0.960 |
Why?
|
| Psychotherapy, Brief | 2 | 2019 | 53 | 0.880 |
Why?
|
| Transgender Persons | 2 | 2023 | 68 | 0.860 |
Why?
|
| Child Behavior | 2 | 2019 | 236 | 0.780 |
Why?
|
| Problem Behavior | 1 | 2022 | 40 | 0.720 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2022 | 240 | 0.610 |
Why?
|
| Hypothalamic Diseases | 1 | 2019 | 40 | 0.600 |
Why?
|
| Hamartoma | 1 | 2019 | 51 | 0.600 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2019 | 173 | 0.600 |
Why?
|
| Adaptation, Psychological | 4 | 2013 | 431 | 0.540 |
Why?
|
| Parenting | 2 | 2013 | 356 | 0.520 |
Why?
|
| Diabetes Mellitus, Type 1 | 7 | 2014 | 872 | 0.500 |
Why?
|
| Models, Statistical | 1 | 2017 | 485 | 0.430 |
Why?
|
| Abnormalities, Multiple | 5 | 2019 | 973 | 0.400 |
Why?
|
| Verbal Learning | 1 | 2013 | 67 | 0.390 |
Why?
|
| Mothers | 1 | 2016 | 369 | 0.390 |
Why?
|
| Depressive Disorder | 1 | 2016 | 462 | 0.380 |
Why?
|
| Child | 25 | 2022 | 26214 | 0.380 |
Why?
|
| Stress, Psychological | 2 | 2014 | 557 | 0.370 |
Why?
|
| Cognition | 3 | 2009 | 817 | 0.370 |
Why?
|
| Child Development | 1 | 2014 | 271 | 0.360 |
Why?
|
| Parent-Child Relations | 1 | 2013 | 255 | 0.350 |
Why?
|
| Autism Spectrum Disorder | 1 | 2017 | 439 | 0.350 |
Why?
|
| Neuroimaging | 1 | 2014 | 398 | 0.340 |
Why?
|
| Behavioral Symptoms | 1 | 2011 | 27 | 0.340 |
Why?
|
| Cognition Disorders | 2 | 2014 | 559 | 0.330 |
Why?
|
| Memory | 1 | 2013 | 353 | 0.320 |
Why?
|
| Child, Preschool | 16 | 2020 | 15011 | 0.320 |
Why?
|
| Behavior | 1 | 2009 | 70 | 0.310 |
Why?
|
| Consensus | 1 | 2012 | 528 | 0.300 |
Why?
|
| Outpatient Clinics, Hospital | 2 | 2013 | 72 | 0.300 |
Why?
|
| Parents | 4 | 2022 | 1109 | 0.290 |
Why?
|
| Adolescent | 20 | 2023 | 20832 | 0.290 |
Why?
|
| Syndrome | 4 | 2008 | 1161 | 0.290 |
Why?
|
| Female | 30 | 2023 | 70630 | 0.280 |
Why?
|
| Adaptation, Physiological | 1 | 2009 | 252 | 0.280 |
Why?
|
| Male | 30 | 2023 | 64680 | 0.270 |
Why?
|
| Humans | 43 | 2023 | 130776 | 0.270 |
Why?
|
| Polyhydramnios | 1 | 2007 | 54 | 0.270 |
Why?
|
| Neurocognitive Disorders | 2 | 2020 | 73 | 0.270 |
Why?
|
| Depression | 1 | 2016 | 1327 | 0.260 |
Why?
|
| Failure to Thrive | 1 | 2007 | 88 | 0.260 |
Why?
|
| Child Health Services | 1 | 2008 | 88 | 0.260 |
Why?
|
| Adrenal Hyperplasia, Congenital | 2 | 2018 | 31 | 0.250 |
Why?
|
| Urogenital Abnormalities | 2 | 2020 | 161 | 0.240 |
Why?
|
| Patient Care Team | 2 | 2016 | 556 | 0.240 |
Why?
|
| Patient Compliance | 4 | 2013 | 468 | 0.230 |
Why?
|
| Developmental Disabilities | 4 | 2020 | 772 | 0.220 |
Why?
|
| Anxiety Disorders | 1 | 2011 | 731 | 0.210 |
Why?
|
| Dwarfism | 2 | 2020 | 104 | 0.200 |
Why?
|
| Decision Making | 1 | 2009 | 690 | 0.200 |
Why?
|
| Intellectual Disability | 2 | 2007 | 1077 | 0.190 |
Why?
|
| Terminology as Topic | 2 | 2017 | 226 | 0.180 |
Why?
|
| Social Stigma | 1 | 2023 | 81 | 0.180 |
Why?
|
| Noonan Syndrome | 1 | 2022 | 33 | 0.180 |
Why?
|
| Hyperglycemia | 2 | 2014 | 233 | 0.180 |
Why?
|
| Wnt-5a Protein | 1 | 2020 | 23 | 0.170 |
Why?
|
| Dishevelled Proteins | 1 | 2020 | 42 | 0.160 |
Why?
|
| Phenotype | 6 | 2020 | 4479 | 0.160 |
Why?
|
| Craniofacial Abnormalities | 2 | 2020 | 255 | 0.160 |
Why?
|
| Limb Deformities, Congenital | 1 | 2020 | 117 | 0.150 |
Why?
|
| Heart Defects, Congenital | 4 | 2019 | 1905 | 0.150 |
Why?
|
| Mental Health | 1 | 2023 | 382 | 0.150 |
Why?
|
| Interdisciplinary Communication | 2 | 2017 | 133 | 0.150 |
Why?
|
| Puberty | 2 | 2016 | 103 | 0.140 |
Why?
|
| Adult | 13 | 2020 | 31269 | 0.140 |
Why?
|
| Medicaid | 1 | 2021 | 252 | 0.140 |
Why?
|
| Sex Determination Processes | 1 | 2017 | 11 | 0.140 |
Why?
|
| Genes, ras | 2 | 2008 | 98 | 0.140 |
Why?
|
| Patient Acceptance of Health Care | 3 | 2021 | 497 | 0.130 |
Why?
|
| Young Adult | 6 | 2020 | 10021 | 0.130 |
Why?
|
| Sex Counseling | 1 | 2017 | 6 | 0.130 |
Why?
|
| Mythology | 1 | 2017 | 8 | 0.130 |
Why?
|
| Comorbidity | 1 | 2022 | 1595 | 0.130 |
Why?
|
| Dexamethasone | 1 | 2018 | 253 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2013 | 1502 | 0.130 |
Why?
|
| Intelligence Tests | 2 | 2007 | 62 | 0.120 |
Why?
|
| Turner Syndrome | 1 | 2016 | 44 | 0.120 |
Why?
|
| Gonadal Dysgenesis, 46,XY | 1 | 2016 | 17 | 0.120 |
Why?
|
| Mutation | 4 | 2011 | 6145 | 0.120 |
Why?
|
| Anxiety | 1 | 2023 | 1009 | 0.120 |
Why?
|
| Mother-Child Relations | 1 | 2016 | 81 | 0.120 |
Why?
|
| Cohort Studies | 4 | 2013 | 5089 | 0.120 |
Why?
|
| Ectromelia | 1 | 2015 | 3 | 0.110 |
Why?
|
| Androgen-Insensitivity Syndrome | 1 | 2015 | 26 | 0.110 |
Why?
|
| Social Behavior | 1 | 2017 | 216 | 0.110 |
Why?
|
| Sexual Development | 2 | 2019 | 25 | 0.110 |
Why?
|
| Evidence-Based Practice | 1 | 2016 | 116 | 0.110 |
Why?
|
| Heart | 1 | 2019 | 666 | 0.110 |
Why?
|
| Encephalocele | 1 | 2015 | 65 | 0.110 |
Why?
|
| Practice Guidelines as Topic | 3 | 2017 | 1299 | 0.110 |
Why?
|
| Neuropsychological Tests | 2 | 2015 | 961 | 0.100 |
Why?
|
| Fertility | 1 | 2016 | 258 | 0.100 |
Why?
|
| Germ-Line Mutation | 3 | 2019 | 373 | 0.100 |
Why?
|
| Infant | 6 | 2017 | 13323 | 0.100 |
Why?
|
| Language Tests | 1 | 2013 | 23 | 0.100 |
Why?
|
| Task Performance and Analysis | 1 | 2013 | 75 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 220 | 0.100 |
Why?
|
| Family | 1 | 2016 | 586 | 0.100 |
Why?
|
| Hypoglycemia | 1 | 2014 | 183 | 0.100 |
Why?
|
| Age of Onset | 1 | 2014 | 597 | 0.100 |
Why?
|
| Models, Psychological | 1 | 2013 | 138 | 0.100 |
Why?
|
| Endocrinology | 1 | 2014 | 128 | 0.090 |
Why?
|
| Stress Disorders, Traumatic, Acute | 1 | 2011 | 2 | 0.090 |
Why?
|
| Educational Measurement | 1 | 2014 | 318 | 0.090 |
Why?
|
| Infant, Newborn | 4 | 2017 | 8567 | 0.090 |
Why?
|
| Diabetic Ketoacidosis | 1 | 2013 | 164 | 0.090 |
Why?
|
| Program Evaluation | 1 | 2013 | 442 | 0.090 |
Why?
|
| Brain | 3 | 2019 | 3222 | 0.080 |
Why?
|
| Age Factors | 1 | 2017 | 2849 | 0.080 |
Why?
|
| Manuals as Topic | 1 | 2009 | 10 | 0.080 |
Why?
|
| Risk Factors | 5 | 2015 | 11003 | 0.070 |
Why?
|
| United States | 4 | 2021 | 11834 | 0.070 |
Why?
|
| Vision, Ocular | 1 | 2009 | 117 | 0.070 |
Why?
|
| Surveys and Questionnaires | 2 | 2017 | 4039 | 0.070 |
Why?
|
| Facial Asymmetry | 1 | 2008 | 17 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2009 | 328 | 0.070 |
Why?
|
| Sex Factors | 1 | 2011 | 1341 | 0.060 |
Why?
|
| Texas | 3 | 2013 | 3634 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2013 | 5230 | 0.060 |
Why?
|
| Pregnancy | 4 | 2018 | 7499 | 0.060 |
Why?
|
| Motor Activity | 1 | 2009 | 500 | 0.060 |
Why?
|
| MAP Kinase Signaling System | 1 | 2007 | 304 | 0.060 |
Why?
|
| Hypoglycemic Agents | 1 | 2010 | 475 | 0.060 |
Why?
|
| Heterozygote | 1 | 2007 | 721 | 0.060 |
Why?
|
| Treatment Outcome | 2 | 2013 | 12910 | 0.060 |
Why?
|
| Insulin | 1 | 2010 | 1146 | 0.060 |
Why?
|
| Mental Health Services | 1 | 2008 | 275 | 0.060 |
Why?
|
| Mass Screening | 1 | 2011 | 808 | 0.060 |
Why?
|
| Pediatrics | 1 | 2014 | 1242 | 0.050 |
Why?
|
| Patient Satisfaction | 1 | 2008 | 453 | 0.050 |
Why?
|
| Vocabulary | 1 | 2004 | 20 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2008 | 559 | 0.050 |
Why?
|
| Face | 2 | 2019 | 191 | 0.050 |
Why?
|
| Psychomotor Performance | 2 | 2015 | 167 | 0.050 |
Why?
|
| Prenatal Diagnosis | 2 | 2018 | 650 | 0.050 |
Why?
|
| Aging | 1 | 2009 | 1252 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2008 | 695 | 0.050 |
Why?
|
| Retrospective Studies | 4 | 2021 | 17674 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2022 | 188 | 0.040 |
Why?
|
| ras Proteins | 1 | 2022 | 146 | 0.040 |
Why?
|
| Managed Care Programs | 1 | 2021 | 56 | 0.040 |
Why?
|
| Quality of Life | 1 | 2010 | 2089 | 0.040 |
Why?
|
| Virilism | 1 | 2018 | 13 | 0.040 |
Why?
|
| Genotype | 2 | 2019 | 2611 | 0.040 |
Why?
|
| Hormones | 1 | 2019 | 163 | 0.040 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 201 | 0.030 |
Why?
|
| Sex Preselection | 1 | 2017 | 5 | 0.030 |
Why?
|
| Birth Certificates | 1 | 2017 | 13 | 0.030 |
Why?
|
| Intersectoral Collaboration | 1 | 2017 | 18 | 0.030 |
Why?
|
| Gender Dysphoria | 1 | 2017 | 7 | 0.030 |
Why?
|
| Greece, Ancient | 1 | 2017 | 9 | 0.030 |
Why?
|
| History, Ancient | 1 | 2017 | 53 | 0.030 |
Why?
|
| Ovulation Induction | 1 | 2016 | 38 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2017 | 255 | 0.030 |
Why?
|
| Alleles | 1 | 2020 | 1671 | 0.030 |
Why?
|
| Fertility Preservation | 1 | 2016 | 61 | 0.030 |
Why?
|
| Leukopenia | 1 | 1975 | 45 | 0.030 |
Why?
|
| Gonads | 1 | 2015 | 32 | 0.030 |
Why?
|
| Genitalia | 1 | 2015 | 39 | 0.030 |
Why?
|
| Disease Management | 1 | 2019 | 563 | 0.030 |
Why?
|
| Disclosure | 1 | 2015 | 150 | 0.030 |
Why?
|
| Visual Perception | 1 | 2015 | 127 | 0.030 |
Why?
|
| Androgens | 1 | 2015 | 265 | 0.020 |
Why?
|
| Estrogens | 1 | 2015 | 431 | 0.020 |
Why?
|
| Neoplasms | 3 | 2015 | 2956 | 0.020 |
Why?
|
| Informed Consent | 1 | 2015 | 345 | 0.020 |
Why?
|
| Antipsychotic Agents | 1 | 1975 | 365 | 0.020 |
Why?
|
| Southwestern United States | 1 | 2011 | 46 | 0.020 |
Why?
|
| ROC Curve | 1 | 2013 | 615 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2015 | 3869 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 643 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2019 | 2341 | 0.020 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2017 | 772 | 0.020 |
Why?
|
| Psychology | 1 | 2011 | 56 | 0.020 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2011 | 68 | 0.020 |
Why?
|
| Blood Glucose | 1 | 2014 | 1107 | 0.020 |
Why?
|
| Family Relations | 1 | 2010 | 75 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2022 | 4670 | 0.020 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2010 | 128 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2020 | 3417 | 0.020 |
Why?
|
| Hospitals, Pediatric | 1 | 2013 | 801 | 0.020 |
Why?
|
| Farnesyltranstransferase | 1 | 2008 | 8 | 0.020 |
Why?
|
| Chondroitin Sulfates | 1 | 2008 | 13 | 0.020 |
Why?
|
| Pyloric Stenosis | 1 | 2008 | 8 | 0.020 |
Why?
|
| Psychological Tests | 1 | 2008 | 87 | 0.020 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 75 | 0.020 |
Why?
|
| Mental Disorders | 1 | 1975 | 895 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 828 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2011 | 1462 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2104 | 0.020 |
Why?
|
| Time Factors | 2 | 2015 | 6241 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2010 | 893 | 0.020 |
Why?
|
| Prediabetic State | 1 | 1976 | 66 | 0.010 |
Why?
|
| DNA Mutational Analysis | 1 | 2008 | 788 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 1976 | 161 | 0.010 |
Why?
|
| Carbonic Anhydrases | 1 | 1975 | 22 | 0.010 |
Why?
|
| Digitoxin | 1 | 1975 | 12 | 0.010 |
Why?
|
| Cadmium | 1 | 1975 | 33 | 0.010 |
Why?
|
| Mercury | 1 | 1975 | 31 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2011 | 2126 | 0.010 |
Why?
|
| Hydrolases | 1 | 1975 | 61 | 0.010 |
Why?
|
| Hospitalization | 1 | 2014 | 1934 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2008 | 564 | 0.010 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 1212 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1975 | 96 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2307 | 0.010 |
Why?
|
| Zinc | 1 | 1975 | 128 | 0.010 |
Why?
|
| Prevalence | 1 | 2011 | 2684 | 0.010 |
Why?
|
| Biomarkers | 1 | 2014 | 3400 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2013 | 3716 | 0.010 |
Why?
|
| Caregivers | 1 | 2010 | 573 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2011 | 2937 | 0.010 |
Why?
|
| Base Sequence | 1 | 2008 | 2746 | 0.010 |
Why?
|
| Autoantibodies | 1 | 1976 | 438 | 0.010 |
Why?
|
| Lysosomes | 1 | 1975 | 269 | 0.010 |
Why?
|
| Skin | 1 | 1975 | 547 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 28499 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 1976 | 895 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 1975 | 411 | 0.010 |
Why?
|
| Phenothiazines | 1 | 1975 | 5 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1975 | 18 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 1975 | 406 | 0.010 |
Why?
|
| Kinetics | 2 | 1975 | 1087 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1975 | 1558 | 0.000 |
Why?
|
| Glucose Tolerance Test | 1 | 1976 | 199 | 0.000 |
Why?
|
| Chondro-4-Sulfatase | 1 | 1975 | 1 | 0.000 |
Why?
|
| Acid Phosphatase | 1 | 1975 | 13 | 0.000 |
Why?
|
| Organ Specificity | 1 | 1976 | 397 | 0.000 |
Why?
|
| Cerebroside-Sulfatase | 1 | 1975 | 9 | 0.000 |
Why?
|
| Digitoxigenin | 1 | 1975 | 10 | 0.000 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 1975 | 16 | 0.000 |
Why?
|
| Chromatography, Thin Layer | 1 | 1975 | 43 | 0.000 |
Why?
|
| Pyrophosphatases | 1 | 1975 | 22 | 0.000 |
Why?
|
| Hydroxylation | 1 | 1975 | 50 | 0.000 |
Why?
|
| Guinea Pigs | 1 | 1975 | 149 | 0.000 |
Why?
|
| NADP | 1 | 1975 | 54 | 0.000 |
Why?
|
| HLA Antigens | 1 | 1976 | 225 | 0.000 |
Why?
|
| Cattle | 1 | 1975 | 501 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1975 | 281 | 0.000 |
Why?
|
| Autoimmune Diseases | 1 | 1976 | 265 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1975 | 809 | 0.000 |
Why?
|
| Protein Conformation | 1 | 1975 | 729 | 0.000 |
Why?
|
| Binding Sites | 1 | 1975 | 1144 | 0.000 |
Why?
|
| Protein Binding | 1 | 1975 | 1660 | 0.000 |
Why?
|
| Animals | 3 | 1975 | 33891 | 0.000 |
Why?
|
| Rats | 1 | 1975 | 3411 | 0.000 |
Why?
|
| Drug Stability | 1 | 1975 | 56 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1975 | 191 | 0.000 |
Why?
|
| Temperature | 1 | 1975 | 288 | 0.000 |
Why?
|
| Aged | 1 | 1976 | 20958 | 0.000 |
Why?
|